C/T polymorphism of the intercellular adhesion molecule-1 gene (exon 6, codon 469). A risk factor for coronary heart

Hong Jiang1, Rolf Michael Klein, Dieter Niederacher

  • 1Heart Center Wuppertal, University of Witten-Herdecke, Arrenbergerstr. 20, 42117 Wuppertal, Germany. hong.jiang@uni-duesseldorf.de

Insights

The intercellular adhesion molecule-1 (ICAM-1) C/T gene polymorphism is linked to increased risk of coronary heart disease (CHD) and myocardial infarction (MI). Individuals with TT or TC genotypes show higher susceptibility to these cardiovascular conditions.

Area of Science:

  • Genetics
  • Cardiovascular Medicine
  • Molecular Biology

Background:

  • Intercellular adhesion molecule-1 (ICAM-1) is crucial in endothelial cell-leukocyte interactions and coronary atherosclerosis pathogenesis.
  • A known C/T polymorphism in ICAM-1 exon 6 codon 469 results in an amino acid substitution.
  • Understanding genetic predispositions for cardiovascular disease is vital.

Purpose of the Study:

  • To investigate if the ICAM-1 C/T polymorphism influences the risk of coronary heart disease (CHD).
  • To determine the association between the ICAM-1 C/T polymorphism and myocardial infarction (MI) risk.

Main Methods:

  • Genotyping of ICAM-1 polymorphism using polymerase chain reaction and allele-specific oligonucleotide techniques.
  • Case-control study design involving 349 CHD patients (179 with MI) and 213 controls.
  • Statistical analysis including multivariable logistic regression.

Main Results:

  • Frequencies of the T genotype (TT+TC) were significantly higher in CHD and MI patients compared to controls (P<0.001).
  • Multivariable logistic regression confirmed a significant association between CHD/MI and TT/TC genotypes (P=0.011, OR 2.21).

Conclusions:

  • The TT and TC genotypes of the ICAM-1 gene polymorphism at codon 469 are associated with increased susceptibility to CHD.
  • This ICAM-1 polymorphism may serve as a genetic marker for predicting individual risk of coronary heart disease and myocardial infarction.
Abstract

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Translation01:37

Translation

Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.Translation Produces the Building Blocks of LifeProteins are called the...
Translation01:37

Translation

Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.Translation Produces the Building Blocks of LifeProteins are called the...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Exon Recombination02:32

Exon Recombination

The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes. 
Exon shuffling follows “splice frame rules.” Each exon has three reading...
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...